CooperCompanies Announces New Chair of the Board and Strategic Review
COOSAN RAMON, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today that its Board of Directors has appointed Colleen Jay to succeed current Chair Robert Weiss, effective January 2, 2026. Mr. Weiss will remain on the Board and stand for reelection for the upcoming year, marking his final term. The Company also announced a formal strategic review aimed at identifying opportunities to enhance long-term shareholder value.
CooperCompanies Announces Third Quarter 2025 Results
COOSAN RAMON, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2025.
CooperCompanies to Participate in the Wells Fargo Healthcare Conference
COOSAN RAMON, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will participate in the Wells Fargo Healthcare Conference on Wednesday, September 3, 2025. Al White, President and CEO, will represent the Company in a session scheduled at 3:00 PM ET.
Why Is Contact Lens Maker Cooper Companies Stock Trading Lower On Friday?
COOCooper Companies beats Q2 estimates with $1 billion in sales and raises FY25 EPS forecast despite trimming revenue growth expectations.
Baird Maintains Outperform on Cooper Companies, Lowers Price Target to $97
COOPiper Sandler Reiterates Overweight on Cooper Companies, Lowers Price Target to $105
COOWells Fargo Maintains Overweight on Cooper Companies, Lowers Price Target to $93
COOJP Morgan Downgrades Cooper Companies to Neutral, Lowers Price Target to $76
COOCooper Companies Raises FY2025 Adj EPS Guidance from $3.94-$4.02 to $4.05-$4.11 vs $3.99 Est; Narrows FY2025 Sales Guidance from $4.08B-$4.16B to $4.11B-$4.15B vs $4.12B Est
COOCooper Companies Q2 Adj. EPS $0.96 Beats $0.93 Estimate, Sales $1.00B Beat $995.35M Estimate
COOA Glimpse of Cooper Companies's Earnings Potential
COOWhere Cooper Companies Stands With Analysts
COONeedham Reiterates Hold on Cooper Companiesto Hold
COOBreaking Down Cooper Companies: 5 Analysts Share Their Views
COOStifel Maintains Buy on Cooper Companies, Lowers Price Target to $105
COOJP Morgan Maintains Overweight on Cooper Companies, Lowers Price Target to $110
COOPiper Sandler Reiterates Overweight on Cooper Companies, Lowers Price Target to $115
COOCitigroup Maintains Buy on Cooper Companies, Lowers Price Target to $110
COOBaird Maintains Outperform on Cooper Companies, Lowers Price Target to $107
COONeedham Reiterates Hold on Cooper Companiesto Hold
COOCooper Companies Sees FY25 Adj. EPS $3.94-$4.02 Vs $3.98 Est.; Revenue $4.080B-$4.158B Vs $4.121B Est.
COOCooper Companies Q1 2025 Adj. EPS $0.92 Beats $0.91 Estimate, Sales $964.700M Miss $978.091M Estimate
COO